Nicotinic acid (vitamin B3) is believed to modulate neuronal function and vascular tone in cluster headache patients by influencing prostaglandin metabolism and improving microcirculation. Its vasodilatory properties may help reduce neurovascular inflammation and potentially interrupt the pathological cascade associated with cluster headache attacks. When used therapeutically, nicotinic acid can potentially decrease headache frequency and severity through its complex neuromodulatory effects.